Related topics: glaxosmithkline

Sorry, no news articles match your request. Your search criteria may be too narrow.

GlaxoSmithKline

GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom. It is the world's third-largest pharmaceutical company measured by revenues (after Johnson & Johnson and Pfizer).

GSK has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions. It also has a large consumer healthcare division which produces and markets oral healthcare and nutritional products and over-the-counter medicines including Sensodyne, Boost, Horlicks and Gaviscon.

GSK has its primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has a secondary listing on the New York Stock Exchange.

This text uses material from Wikipedia, licensed under CC BY-SA